Regenerex Pharma (RGPX) Total Liabilities (2010 - 2025)
Regenerex Pharma (RGPX) reported Total Liabilities of $5.3 million for Q3 2025, down 1.36% year-over-year from $5.4 million in Q3 2024, and little changed on a QoQ basis from $5.3 million in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Total Liabilities data on file, last reported at $5.3 million in Q3 2025.
- Quarterly Total Liabilities fell 1.36% year-over-year to $5.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.3 million (down 1.36% YoY) and the FY2025 annual result came in at $5.4 million, up 12.24% from the prior year.
- Total Liabilities was little changed at $5.3 million in Q3 2025 per RGPX's latest filing, from $5.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $5.7 million in Q4 2024 and bottomed at $845496.0 in Q1 2021.
- The 5-year median for Total Liabilities is $2.1 million (2023), against an average of $3.0 million.
- The widest annual swing landed in 2023, when Total Liabilities surged 340.72%; it then decreased 1.36% in 2025.
- Tracing RGPX's Total Liabilities over 5 years: stood at $948583.0 in 2021, then increased by 14.55% to $1.1 million in 2022, then soared by 335.14% to $4.7 million in 2023, then grew by 20.57% to $5.7 million in 2024, then dropped by 6.74% to $5.3 million in 2025.
- Per Business Quant, the three latest RGPX Total Liabilities figures stand at $5.3 million (Q3 2025), $5.3 million (Q2 2025), and $5.4 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 5.42 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 4.73 Mn |
| Sep 30, 2023 | 4.57 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 948,583.00 |
| Sep 30, 2021 | 914,756.00 |
| Jun 30, 2021 | 880,067.00 |
| Mar 21, 2021 | 845,496.00 |
| Dec 31, 2020 | 803,046.00 |
| Sep 30, 2020 | 770,954.00 |
| Jun 30, 2020 | 746,277.00 |
| Mar 31, 2020 | 740,441.00 |
| Dec 31, 2019 | 695,725.00 |
| Sep 30, 2019 | 671,681.00 |
| Jun 30, 2019 | 546,630.00 |
| Mar 31, 2019 | 475,308.00 |
| Dec 31, 2018 | 394,634.00 |
| Sep 30, 2018 | 356,238.00 |
| Jun 30, 2018 | 352,820.00 |
| Mar 31, 2018 | 336,175.00 |
| Dec 31, 2017 | 335,779.00 |
| Sep 30, 2017 | 326,221.00 |
| Jun 30, 2017 | 314,788.00 |
| Mar 31, 2017 | 281,685.00 |
| Nov 30, 2014 | 693,479.00 |
| Aug 31, 2014 | 757,599.00 |
| May 31, 2014 | 699,328.00 |
| Feb 28, 2014 | 1.91 Mn |
| Nov 30, 2013 | 1.75 Mn |
| Aug 31, 2013 | 1.50 Mn |
| May 31, 2013 | 1.27 Mn |
| Feb 28, 2013 | 1.05 Mn |
| Nov 30, 2012 | 815,097.00 |
| Aug 31, 2012 | 334,308.00 |
| May 31, 2012 | 328,171.00 |
| Feb 29, 2012 | 329,100.00 |
| Nov 30, 2011 | 199,123.00 |
| Aug 31, 2011 | 38,046.00 |
| Nov 30, 2010 | 29,133.00 |
| Aug 31, 2010 | 13,817.00 |